Efficacy and safety of subsequent radiotherapy in patients with advanced-stage hepatocellular carcinoma treated with immune checkpoint inhibitors.

Authors:
Ning C; Jia J; Zhang X; Sun J; Wang Y and 7 more

Journal:
Hepatobiliary Surg Nutr

Publication Year: 2023

DOI:
10.21037/hbsn-23-134

PMCID:
PMC10727817

PMID:
38115944

Journal Information

Full Title: Hepatobiliary Surg Nutr

Abbreviation: Hepatobiliary Surg Nutr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nutrition & Dietetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-134/coif). H.Z. serves as an unpaid Deputy Editor-in-Chief of Hepatobiliary Surgery and Nutrition and X.S. serves as an unpaid editorial board member of Hepatobiliary Surgery and Nutrition. The other authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: This work was supported by the National High Level Hospital Clinical Research Funding ( 2022-PUMCH-B-128 ); the CAMS Innovation Fund for Medical Sciences ( 2022-I2M-C&T-A-003 ); and the CSCO-Hengrui Cancer Research Fund ( Y-HR2020MS-0415 and Y-HR2020QN-0414 )."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025